Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
2019 · Blood · 293 citations
https://doi.org/10.1182/blood.2019002220
K
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
1.5K
Citations
18
h-index
28
i10-index
Ke Xu is an academic researcher from University College London Hospitals NHS Foundation Trust. The author has contributed to research in topics: Epigenetics and DNA Methylation & Cancer Genomics and Diagnostics & Neuroblastoma Research and Treatments. The author has an h-index of 18, co-authored 90 publications.
ORCID: 0000-0002-8130-1109Papers by this author
worksStructure and evolution of double minutes in diagnosis and relapse brain tumors
2018 · Acta Neuropathologica · 87 citations
https://doi.org/10.1007/s00401-018-1912-1
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
2020 · Acta Neuropathologica · 67 citations
https://doi.org/10.1007/s00401-020-02171-5
Identification of novel factors involved in or regulating initiation of DNA replication by a genome-wide phenotypic screen in<i>Saccharomyces cerevisiae</i>
2010 · Cell Cycle · 23 citations
https://doi.org/10.4161/cc.9.21.13679
Genome-wide analysis indicates association between heterozygote advantage and healthy aging in humans
2019 · BMC Genetics · 17 citations
https://doi.org/10.1186/s12863-019-0758-4
Genomic profiling of circulating tumor DNA for childhood cancers
2024 · Leukemia · 8 citations
https://doi.org/10.1038/s41375-024-02461-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat